Results 11 to 20 of about 80,703 (286)
Detection of chromosomal regions showing differential gene expression in human skeletal muscle and in alveolar rhabdomyosarcoma [PDF]
BMC Bioinformatics, 2004 Background Rhabdomyosarcoma is a relatively common tumour of the soft tissue, probably due to regulatory disruption of growth and differentiation of skeletal muscle stem cells.
Bortoluzzi Stefania +2 more
doaj +3 more sources
Nature Reviews Disease Primers, 2019 Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and represents a high-grade neoplasm of skeletal myoblast-like cells. Decades of clinical and basic research have gradually improved our understanding of the pathophysiology of RMS and helped to optimize clinical care.
Stephen X, Skapek +7 more
+8 more sources
Pediatric Blood & Cancer, 2021 AbstractRhabdomyosarcoma is a heterogeneous disease both in presentation and histology. Improvements in a multimodality therapy resulted in the improved overall survival for patients with a low‐risk and intermediate‐risk disease but not for patients with a metastatic disease. We reviewed and contrasted the North American and European practice patterns,
Raphael L. Yechieli +10 more
openaire +3 more sources
Current Oncology, 2022 Background/Aim: Patients with uterine sarcoma comprise 2–5% of all patients with uterine malignancies; however, the morbidity of uterine sarcoma is low compared with that of other gynecological cancers.
Saya Tamura +5 more
doaj +1 more source
MYBPC2 and MYL1 as Significant Gene Markers for Rhabdomyosarcoma
Technology in Cancer Research & Treatment, 2021 Background: Rhabdomyosarcoma is the most common soft tissue tumor in children. Rhabdomyosarcoma commonly results in pain and bleeding caused by tumor compression and is prone to early metastasis and recurrence, which can seriously affect the therapeutic ...
Zihang Chen MS +3 more
doaj +1 more source
Relapsed Rhabdomyosarcoma [PDF]
Journal of Clinical Medicine, 2021 Relapsed rhabdomyosarcoma (RMS) represents a significant therapeutic challenge. Nearly one-third of patients diagnosed with localized RMS and over two-thirds of patients with metastatic RMS will experience disease recurrence following primary treatment, generally within three years.
Christine M. Heske, Leo Mascarenhas
openaire +2 more sources
Rhabdomyosarcoma of the uterus in an adult patient with osteopetrosis: a case report
Journal of Medical Case Reports, 2021 Background Uterine sarcoma accounts for 3–7% of uterine malignant neoplasms. It is more aggressive than epithelial neoplasms, and patients have a poor prognosis. Rhabdomyosarcoma is classified as a heterologous uterine sarcoma. It is the most common soft
Soheila Aminimoghaddam +2 more
doaj +1 more source
Femoral intraosseous rhabdomyosarcoma: a case report and literature review
Brazilian Journal of Oncology, 2021 Introduction: Rhabdomyosarcoma is the most common soft tissue sarcoma in childhood. However, primary bone rhabdomyosarcoma is a rare entity with some few cases reported. Case Report: We present a case of a 19-year-old female patient referred
Dan Carai Maia Viola +6 more
doaj +1 more source
Chorein sensitive microtubule organization in tumor cells [PDF]
PeerJ, 2023 Background The purpose of this study is to analyzed the involvement of chorein in microtubules organization of three types of malignant; rhabdomyosarcoma tumor cells (ZF), rhabdomyosarcoma cells (RH30), and rhabdomyosarcoma cells (RD).
Saad Alkahtani +3 more
doaj +2 more sources
Journal of Medical Imaging and Radiation Oncology, EarlyView., 2023 Summary Proton Beam Therapy (PBT) has the potential to improve paediatric cancer care by reducing radiation exposure and thus long‐term toxicities. Ethical concerns and debates surrounding the treatment, such as eligibility and accessibility, are ongoing in Australia. The Australian Bragg Centre for Proton Therapy and Research (ABCPTR) (named after Sir
Jeremy Khong +10 more
wiley +1 more source